No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Specialty Business Services
WDB coco Co., Ltd. offers specialized contractual services to pharmaceutical companies throughout Japan. The firm plays a crucial role in advancing pharmaceuticals and medical devices, with a particular focus on safety information management, support for safety data systems, clinical research assistance, and post-market safety operations. Its offerings also encompass translation and quality control document preparation, additional clinical study support, and personnel dispatch. Furthermore, WDB coco provides comprehensive post-marketing surveillance (PMS) solutions, which include securing agreements with healthcare facilities, explaining survey protocols, collecting survey forms, conducting detailed monitoring (like re-surveys), managing a central case registration center, handling data, and performing statistical analyses. Established in 1984, the company's headquarters are located in Tokyo, Japan.
www.wdbcoco.comNo one on the platform currently holds 7079.T.
No tracked institution reports a position in 7079.T as of their last filing.
No one on the platform has traded 7079.T yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 61.2% | 114.5% | — | — | — | |
| Rev. Growth % | -9.6% | 13.4% | ||||
| Profit Margin % | 14.1% | 17.2% | ||||
| Free Cash Flow Margin % | 10.8% | 15.9% | ||||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $6.1B | +8.9% | $457.40 | $457.40–$457.40 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 7079.TWDB coco Co., Ltd. | $2578.00 | +1.58% | $6.2B | — |
| 2373.TCare Twentyone Corporation | $447.00 | +0.00% | $6.0B | — |
| 3386.TCosmo Bio Company,Limited | $1240.00 | -0.24% | $7.0B | — |
| 4539.TNippon Chemiphar Co., Ltd. | $1550.00 | +0.00% | $5.6B | — |
| 4582.TSymBio Pharmaceuticals Limited | $56.00 | +0.00% | $3.1B | — |
| 4586.TMedRx Co., Ltd | $61.00 | +1.67% | $3.6B | — |
| 4883.TModalis Therapeutics Corporation | $32.00 | -3.03% | $3.1B | — |
Source: Financial Modeling Prep · peers by sector/industry